Men With Hidradenitis Suppurativa Perceive Better Physician Communication

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 2, 2025.

via HealthDay

WEDNESDAY, July 2, 2025 -- Male patients with hidradenitis suppurativa (HS) perceive better physician communication with respect to demonstrating respect, listening, and explanations, according to a study published online June 19 in The Journal of Dermatology.

Lucy F. Harvey, from the Keck School of Medicine of USC in Los Angeles, and colleagues conducted a population-based cross-sectional study using data from the Medical Expenditure Panel Survey from 2002 to 2015 and 2018. Male and female patients' perceived quality of physician communication was examined among 91,619 patients with HS aged 21 to 85 years (27.18 percent male and 72.52 percent female).

The researchers found that female patients perceived that clinicians were significantly worse at demonstrating respect, listening, and explaining concepts compared with male patients on multivariable linear regression adjusting for age, race, ethnicity, income, insurance, education, and medical comorbidities. In terms of perceptions of time spent with clinicians, no significant difference was seen for female and male patients. Both male and female patients perceived that female physicians better spent time with them than male physicians (3.71 versus 3.32).

"Because HS is a condition that primarily impacts female patients, physicians may need to be especially considerate of how they are communicating with female patients with the disease," the authors write.

One author disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-03 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords